Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:
Catherine Avril Declared no potential conflict of interest.
Jean-Daniel Baki Declared no potential conflict of interest.
Paul Barriere Declared receipt of honoraria or consultation fees from Schering-Plough.
Arnaud Basdevant Declared receipt of grants and contracts from Abbott, Msd, Novo, Lilly, Roche, GSK.
Isabelle Cedrin-Durnerin Declared no potential conflict of interest.
Paul Devroey Declared receipt of grants and contracts from Ferring, MSD, Merck Serono, Besins.
Renato Fanchin Declared no potential conflict of interest.
Human Mousavi Fatemi Declared receipt of honoraria or consultation fees from Ferring, MSD, Merck Serono.
Bart C.J.M. Fauser Declared receipt of grants and fees from Andromed, Ardana, Ferring, Genocvvum, Merck Serono, Organon, Pantharei Bioscience, PregLem, Shering, Schering Plough, Serono, Wyeth.
Marco Filicori Declared no potential conflict of interest.
Nick Finer Declared receipt of honoraria or consultation fees from Abbott laboratories, NovoNordisk, Merck, Johnson & Johnson. Declared participation in a company sponsored speaker’s bureau: Abbott laboratories, NovoNordisk.
Robert Fischer Declared receipt of honoraria or consultation fee from SSIF.
Samir Hamamah Declared receipt of grants and contracts from AFM, Ferring, Schering Plough and honoraria from Ferring.
Jean Noël Hugues Declared receipt of honoraria or consultation fee from Merck Serono.
Peter Humaidan Declared grants and honoraria from Organon and Merck Serono.
Martin M. Matzuk Declared no potential conflict of interest.
Philippe Monget Declared no potential conflict of interest.
Olivier Pirrello Declared no potential conflict of interest.
Laura Rienzi Declared no potential conflict of interest.
Paul Sagot Declared no potential conflict of interest.
Jerome F. Strauss III Declared receipt of grants and contracts from NIH, receipt of honoraria or consultation fees from Serono, Schering Plough, and to be member of a company advisory board, board of directors of Femme Pharma, Stemlifeline, Matrix Pharma.
Géraldine Viot Declared no potential conflict of interest.
Dagan Wells Declared receipt of grants and contracts from EMD Serono, GEMA Diagnostics and to be stakeholder in a company: Reprogenetics UK Ltd.
The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of May 14, 2010.
Philippe Bouchard
Sophie Christin-Maitre
Christophe Lelaidier
François Olivennes
Pascal Piver
Bruno Salle
